HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helen V Danesh-Meyer Selected Research

Ophthalmic Solutions (Eye Drops)

9/2015Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helen V Danesh-Meyer Research Topics

Disease

14Glaucoma
01/2023 - 04/2006
11Optic Nerve Diseases (Optic Neuropathy)
01/2022 - 06/2004
8Inflammation (Inflammations)
01/2019 - 03/2006
6Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
02/2024 - 06/2003
5Disease Progression
01/2018 - 07/2011
4Ganglion Cysts (Ganglion)
01/2024 - 01/2010
4Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2014 - 01/2010
3Neoplasms (Cancer)
02/2024 - 05/2008
3Cataract (Cataracts)
01/2022 - 01/2013
3Diabetic Retinopathy (Retinopathy, Diabetic)
01/2019 - 03/2016
3Macular Degeneration (Age-Related Maculopathy)
10/2017 - 04/2008
2Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
05/2024 - 01/2022
2Myasthenia Gravis
02/2024 - 02/2014
2Eye Diseases (Eye Disease)
01/2024 - 01/2022
2COVID-19
01/2024 - 12/2020
2Herpes Zoster Ophthalmicus
10/2022 - 03/2021
2Brain Concussion (Cerebral Concussion)
01/2022 - 01/2022
2Uveitis
01/2022 - 03/2021
2Gliosis
01/2019 - 01/2018
2Edema (Dropsy)
10/2017 - 03/2016
2Ischemia
10/2017 - 10/2015
2Wounds and Injuries (Trauma)
10/2017 - 04/2014
2Hypoxia (Hypoxemia)
04/2014 - 02/2012
2Reperfusion Injury
03/2012 - 02/2012
2Optic Nerve Injuries
06/2011 - 11/2008
2Erectile Dysfunction
07/2009 - 11/2007
1Acute Promyelocytic Leukemia
05/2024
1Optic Neuritis (Retrobulbar Neuritis)
02/2024
1Leukoencephalopathies
02/2024
1Atrophy
01/2024
1Schizophrenia (Dementia Praecox)
01/2024
1Metabolic Diseases (Metabolic Disease)
01/2024
1Stroke (Strokes)
10/2022
1Exanthema (Rash)
10/2022
1Epiretinal Membrane (Epiretinal Membranes)
01/2022
1Amblyopia (Lazy Eye)
01/2022
1Astigmatism
01/2022
1Nevus (Nevi)
01/2022
1Presbyopia
01/2022
1Refractive Errors (Refractive Error)
01/2022
1Scleritis (Episcleritis)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Corneal Perforation
03/2021
1Band-Shaped Corneal Dystrophy
03/2021
1Neuromyelitis Optica (Devic's Disease)
03/2021
1Conjunctivitis
01/2021
1Geographic Atrophy
01/2019
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2018
1Migraine Disorders (Migraine)
10/2017
1Neuroinflammatory Diseases
10/2017
1Mucolipidoses (Sialidosis)
09/2016
1Retinal Diseases
03/2016
1Nervous System Trauma
01/2016
1Huntington Disease (Huntington's Disease)
11/2015
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
10/2015

Drug/Important Bio-Agent (IBA)

20Retinaldehyde (Retinal)IBA
01/2024 - 12/2006
15Connexin 43 (Connexin43)IBA
01/2019 - 11/2008
6Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2012
3ConnexinsIBA
10/2017 - 01/2014
3Peptides (Polypeptides)IBA
01/2016 - 07/2013
2Acetazolamide (Diamox)FDA LinkGeneric
01/2022 - 01/2007
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2016 - 02/2014
2Drinking WaterIBA
01/2010 - 09/2008
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
07/2009 - 11/2007
2Phosphodiesterase 5 InhibitorsIBA
07/2009 - 11/2007
1Arsenic Trioxide (Trisenox)FDA Link
05/2024
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2024
1Immune Checkpoint InhibitorsIBA
02/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024
1VaccinesIBA
01/2024
1Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2024
1Antiviral Agents (Antivirals)IBA
10/2022
1Immunoglobulin G (IgG)IBA
03/2021
1Myelin-Oligodendrocyte GlycoproteinIBA
03/2021
1CannabinoidsIBA
03/2021
1Edetic Acid (EDTA)FDA Link
03/2021
1Viral RNAIBA
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2020
1InflammasomesIBA
01/2019
1CytokinesIBA
01/2018
1Antiglaucoma AgentsIBA
01/2018
1Adenosine Triphosphate (ATP)IBA
10/2017
1tonabersatIBA
10/2017
1OligosaccharidesIBA
09/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1AcidsIBA
10/2015
114-3-3 Proteins (14-3-3 Protein)IBA
10/2015
1Ophthalmic Solutions (Eye Drops)IBA
09/2015

Therapy/Procedure

8Therapeutics
05/2024 - 06/2004
5Trabeculectomy (Trabeculoplasty)
01/2023 - 09/2008
3Radiotherapy
04/2014 - 06/2004
3Lasers (Laser)
04/2010 - 12/2006
2Phacoemulsification
12/2020 - 01/2013
2Intravitreal Injections
01/2018 - 10/2015
2Aftercare (After-Treatment)
04/2008 - 06/2004
1Eyeglasses (Spectacles)
01/2022
1Intraocular Lenses (Intraocular Lens)
01/2022
1Anesthesia
12/2020
1Elective Surgical Procedures
12/2020
1Surgical Decompression
11/2019